3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other solid neoplasm
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Lymphoma
8
Leukemia, Myeloid, Acute
7
Neutropenia
5
Breast Neoplasms
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Multiple Myeloma
3
Leukemia, Monocytic, Acute
3
Leukemia, Biphenotypic, Acute
3
Uterine Cervical Neoplasms
2
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Osteosarcoma
2
Myelodysplastic Syndromes
2
Lymphoma, Non-Hodgkin
2
Leukemia, Myelomonocytic, Chronic
2
Hodgkin Disease
2
Hematologic Neoplasms
2
Wilms Tumor
1
Triple Negative Breast Neoplasms
1
Thoracic Neoplasms
1
Solid Tumors
1
Small Cell Lung Carcinoma
1
Sarcoma, Myeloid
1
Sarcoma, Clear Cell
1
Rhabdoid Tumor
1
Retinoblastoma
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Interventions
Cyclophosphamide
12
Etoposide
11
Granulocyte Colony-Stimulating Factor
7
Filgrastim
7
Carboplatin
7
etoposide phosphate
6
Vincristine
5
Methotrexate
5
Cisplatin
5
fludarabine
4
Topotecan
4
Thiotepa
4
Stem Cell Transplantation
4
Radiotherapy
4
Mesna
4
Melphalan
4
Temozolomide
3
Sirolimus
3
Ifosfamide
3
Busulfan
3
Automobiles
3
selinexor
2
sargramostim
2
fludarabine phosphate
2
Peripheral Blood Stem Cell Transplantation
2
Nivolumab
2
Leucovorin
2
Ipilimumab
2
Hydrocortisone
2
Gemcitabine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Rhabdoid Tumor
×
pegylated granulocyte colony-stimulating factor
×
Clear all
NCT02390843
2020-04-03
AflacST1402
Emory University
Phase 1
Completed
13 enrolled